CooperCompanies stock edges higher as investors digest last quarter figures

CooperCompanies stock is trading in the upper 60 dollar range as of September 3, 2026, while investors weigh the company’s most recent quarterly earnings and outlook for its contact lens and women’s health businesses.

CooperCompanies stock (ISIN US2166481027) is quoted at 69.73 USD as of September 3, 2026, according to a stock overview that lists the shares opening at 69.73 USD that day. For retail investors, this places the company in the high 60 dollar range while the market digests the most recent quarterly earnings and guidance for its medical device businesses.

Recent earnings and guidance in focus

According to an earnings calendar summary by Zacks, the last reported quarter for The Cooper Companies showed earnings per share of 0.96 USD, ahead of a consensus estimate of 0.93 USD for that period. This represents a positive earnings surprise of 3.23 percent for the quarter ended in fiscal 2025 and underlines that the company managed to beat expectations in its latest available set of results.

For the next earnings release, Zacks data indicate that the consensus forecast stands at 1.06 USD per share, implying a year over year increase of 10.42 percent versus the 0.96 USD actually reported in the prior quarter of fiscal 2025. While this estimate relates to a future reporting date expected on August 27, 2025 in the Zacks overview, it still offers investors a concrete benchmark for how analysts currently see the company’s earnings trajectory after the last quarter.

Analyst expectations and investor perspective

The same Zacks earnings calendar notes that The Cooper Companies plans to report its next quarterly earnings around August 27, 2025 and highlights that the prior quarter’s 0.96 USD in earnings per share exceeded consensus by 0.03 USD. From an investor perspective, this beat against expectations, coupled with double digit percentage growth embedded in the forecast 1.06 USD per share, suggests that profitability in the company’s core segments is trending upward compared with the previous reporting period of fiscal 2025.

At the current share level of 69.73 USD as opened on September 3, 2026, CooperCompanies stock reflects these expectations without being at an extreme valuation level. Investors who follow the medical device space can thus compare a mid to high double digit share price with low single digit dollar earnings per share, and with a forecast that implies more than ten percent earnings growth versus the last reported quarter in fiscal 2025.

Contact lenses and women’s health products

CooperCompanies operates through two main businesses that matter for revenue and earnings: a contact lens division and a women’s health division. The contact lens arm focuses on specialty lenses including daily disposable and silicone hydrogel products that typically generate recurring revenue as patients refill prescriptions. The women’s health business includes fertility and other gynecological products sold to clinics and hospitals, adding diversification to the revenue stream compared with pure contact lens providers.

For investors, both segments influence how earnings per share figures such as the 0.96 USD reported for the last quarter of fiscal 2025 and the forecast 1.06 USD per share for the next expected quarter translate into actual top line and margin performance. Higher growth in specialty contact lenses or in fertility related products can support the double digit percentage uplift embedded in the 10.42 percent year over year earnings growth expectation that analysts currently have penciled in.

Stock level and trading venue

CooperCompanies shares trade in the United States under the ticker COO on a major US exchange, with prices quoted in USD. A stock overview published on September 3, 2026 shows the shares at 69.73 USD at the open that day, offering a concrete price reference as of that date. When compared with the last reported earnings per share of 0.96 USD for a fiscal 2025 quarter, this price level represents a multiple of tens of times earnings, which investors must weigh against the expected 10.42 percent earnings growth implied by the 1.06 USD per share forecast in the Zacks calendar.

CooperCompanies at a glance

• Company: CooperCompanies Inc.
• ISIN: US2166481027
• Ticker: COO
• Trading venue: NYSE
• Price (as of September 3, 2026): 69.73 USD
• Sector / Industry: Health Care / Medical Devices
• Index membership: S&P 500